Digest Network Come funziona
Network
/
Società
Me
Non verificato

Median Technologies

Di cosa scriviamo

Attrezzature medico-sanitarieBiotecnologiaOncologiaSaluteTecnica

37 comunicati stampa

Guarda tutti i comunicati
02/03/2026
Fiere
Industria
Eventi
Biotecnologia
Tecnica
Sanità
Salute
Medicina nucleare
Farmaceutica
Oncologia
Tecnologie Varie
Attrezzature medico-sanitarie
Software
Median Technologies to Showcase eyonis® LCS, Its AI/ML-based Software as a Medical Device for Lung Cancer Screening, at the European Congress of Radiology
Fonte
Median Technologies
Emittente
Business Wire
1.00
0
27/02/2026
Eventi
Web e Social Network
Tecnica
Attrezzature medico-sanitarie
Software
Biotecnologia
Salute
Farmaceutica
Oncologia
Median Technologies to present at the TD Cowen 46th Annual Health Care Conference
Fonte
Median Technologies
Emittente
Business Wire
1.00
0
23/02/2026
Web e Social Network
Industria
Tecnica
Igiene alimentare
Software
Biotecnologia
Medicina nucleare
Farmaceutica
Salute
Oncologia
Median Technologies to Host Webcasts Highlighting Strategic Advances Driving U.S. Deployment of eyonis® LCS
Fonte
Median Technologies
Emittente
Business Wire
1.00
0
18/02/2026
FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.
Fonte
Median Technologies
Emittente
Business Wire
1.00
0
12/02/2026
Mercato del lavoro
Industria
Tecnica
Attrezzature medico-sanitarie
Igiene alimentare
Software
Biotecnologia
Medicina nucleare
Salute
Oncologia
Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United States
Fonte
Median Technologies
Emittente
Business Wire
1.00
0
09/02/2026
Industria
Software
Medicina nucleare
Farmaceutica
Oncologia
Attrezzature medico-sanitarie
Tecnica
Medicina - Varie
Biotecnologia
Igiene alimentare
Salute
Median Technologies Receives FDA 510(k) Clearance for eyonis® LCS, the First AI Tech-Based Detection and Diagnosis Device for Lung Cancer Screening
Fonte
Median Technologies
Emittente
Business Wire
1.00
0
19/01/2026
Software
Medicina nucleare
Farmaceutica
Oncologia
Attrezzature medico-sanitarie
Tecnica
Medicina - Varie
Biotecnologia
Igiene alimentare
Salute
Industria
Median Technologies Reports Landmark 2025 Performance With Major Regulatory and Commercial Milestones Ahead in 2026
Fonte
Median Technologies
Emittente
Business Wire
1.00
0
08/12/2025
Mercato del lavoro
Industria
Attrezzature medico-sanitarie
Salute
Medicina nucleare
Oncologia
Median Technologies Partners With Leading U.S. Healthcare Company to Bring eyonis® LCS to Patients Across the U.S. and Europe
Fonte
Median Technologies
Emittente
Business Wire
1.00
0
25/11/2025
Industria
Eventi
Tecnica
Attrezzature medico-sanitarie
Tecnologie Varie
Software
Sanità
Biotecnologia
Farmaceutica
Salute
Oncologia
Median Technologies to Showcase AI-Powered Software as a Medical Device eyonis® LCS for Lung Cancer Screening at the RSNA 2025 Annual Meeting
Fonte
Median Technologies
Emittente
Business Wire
1.00
0
03/11/2025
Software
Biotecnologia
Oncologia
Salute
Attrezzature medico-sanitarie
Tecnica
Mercato del lavoro
Median Technologies Appoints Didric Cederholm to Its Board of Directors
Fonte
Median Technologies
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0